In the suggested model, paracrine IL-6 signalling from tumour cells also activated p-STAT3 and IL-6 expression in stromal components–namely endothelial cells, CAFs (cancer-associated fibroblasts), and myeloid cells. The gene discussed is STAT3; the disease is neoplasm.